Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194,549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
Wan JL, Wang B, Wu ML, Li J, Gong RM, Song LN, Zhang HS, Zhu GQ, Chen SP, Cai JL, Xing XX, Wang YD, Yang Y, Cai CZ, Huang R, Liu H, Dai Z. Wan JL, et al. Among authors: li j. Cancer Lett. 2022 Aug 10;541:215750. doi: 10.1016/j.canlet.2022.215750. Epub 2022 May 21. Cancer Lett. 2022. PMID: 35609735
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier.
Lu Z, Chen H, Jiao X, Zhou W, Han W, Li S, Liu C, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li Y, Li J, Li Y, Brock M, Zhang H, Shen L. Lu Z, et al. Among authors: li s, li y, li j. J Immunother Cancer. 2020 Aug;8(2):e000631. doi: 10.1136/jitc-2020-000631. J Immunother Cancer. 2020. PMID: 32792359 Free PMC article.
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.
Wang Y, Chen H, Jiao X, Wu L, Yang Y, Zhang J, Wu L, Liu C, Zhuo N, Li S, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li J, Li Y, Lu Z, Zhang H, Shen L. Wang Y, et al. Among authors: li s, li y, li j. Cancer Immunol Immunother. 2022 Jan;71(1):111-120. doi: 10.1007/s00262-021-02966-9. Epub 2021 May 24. Cancer Immunol Immunother. 2022. PMID: 34028566 Free PMC article.
Efficacy, Safety, and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial.
Lu M, Zhang P, Zhang Y, Li Z, Gong J, Li J, Li J, Li Y, Zhang X, Lu Z, Wang X, Zhou J, Peng Z, Wang W, Feng H, Wu H, Yao S, Shen L. Lu M, et al. Among authors: li y, li z, li j. Clin Cancer Res. 2020 May 15;26(10):2337-2345. doi: 10.1158/1078-0432.CCR-19-4000. Epub 2020 Feb 21. Clin Cancer Res. 2020. PMID: 32086343 Clinical Trial.
194,549 results
You have reached the last available page of results. Please see the User Guide for more information.